According to Murfitt L et al., the loss of cavelion-3 might lead to increased nitrosylation of the ryanodine receptor by decreasing the inhibitory effect of caveolin-3 on eNOS, thus indicating another mechanism underlying the protective effect of caveolin-3 on diabetic cardiomyopathy [54]. Here, CAV3 is linked to diabetic cardiomyopathy.